Annual Report in Form 20F for the fiscal year ended March 31, 2025 filed with United States Securities and Exchange Commission
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has filed its Annual Report in Form 20-F with the United States Securities and Exchange Commission for the fiscal year ended March 31, 2025. The report contains annual consolidated financial statements prepared under IFRS, as required for companies listed on US stock exchanges. The company is listed on the NSE, BSE, NYSE, and NSE IFSC. The full Form 20-F is available on the company's website for investors and public reference.
This is a routine regulatory compliance filing required under SEBI Listing Regulations and US SEC rules for Dr. Reddy's NYSE listing. It does not signal any change in business performance; investors should review the Form 20-F for detailed financial and operational disclosures for FY25.